AlvaBuilder: A Software for De Novo Molecular Design.

Area of Science:

• Computational chemistry
• Medicinal chemistry
• Drug discovery

Background:

• De novo molecular design is crucial for identifying novel drug candidates.
• Existing methods may lack user-friendliness or flexibility in defining molecular characteristics.
• The need for software that generates syntactically valid molecules based on specific criteria is high.

Purpose of the Study:

• To introduce AlvaBuilder, a software tool for de novo molecular design.
• To demonstrate the utility of AlvaBuilder in designing new compounds for a specific case study.
• To showcase the software's ability to generate molecules with user-defined desirable characteristics.

Main Methods:

• Utilizing a graphical interface for defining molecular characteristics.
• Incorporating molecular descriptors, QSAR/QSPR model predictions, and fragment matching.
• Generating novel molecules by combining fragments from a user-selected training dataset.
• Ensuring syntactic validity of generated molecules.

Main Results:

• AlvaBuilder successfully generated novel molecules with specified desirable characteristics.
• The software demonstrated flexibility in incorporating various design criteria.
• A case study illustrated the practical application of AlvaBuilder in compound design.
• Generated molecules were syntactically valid, ensuring chemical correctness.

Conclusions:

• AlvaBuilder is an effective software tool for de novo molecular design.
• The software facilitates the generation of novel, syntactically valid molecules based on user-defined properties.
• AlvaBuilder offers a user-friendly approach to computational drug design and discovery.